Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Breast Cancer Research and Treatment|June 21, 2013
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancerD Gareth R Evans, Sarah L Ingham, Andrew Baildam, et al.
BMJ (Clinical Research Ed.)|March 2, 2002
Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trialPaola Dey, Nigel Bundred, Alan Gibbs, et al.
Breast Cancer Research and Treatment|November 20, 2013
Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referralSarah L Ingham, Matthew Sperrin, Andrew Baildam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trialNigel J Bundred, Angela Cramer, Julie Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Cancers|December 15, 2020
Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020)Anthony Howell, Ashu Gandhi, Sacha Howell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSusan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Pageof 1